Meta Information:
{'charset': 'UTF-8'}
{'name': 'robots', 'content': 'max-image-preview:large'}
{'name': 'viewport', 'content': 'width=device-width, initial-scale=1'}
{'property': 'og:locale', 'content': 'en_US'}
{'property': 'og:type', 'content': 'website'}
{'property': 'og:title', 'content': 'GHIAA'}
{'property': 'og:description', 'content': 'The Global Health Innovation Alliance Accelerator'}
{'property': 'og:url', 'content': 'https://ghiaa.org'}
{'property': 'og:site_name', 'content': 'GHIAA'}
{'name': 'generator', 'content': 'WordPress 6.5.3'}
{'name': 'generator', 'content': 'Elementor 3.21.3; features: e_optimized_assets_loading, additional_custom_breakpoints; settings: css_print_method-external, google_font-enabled, font_display-auto'}
{'name': 'msapplication-TileImage', 'content': 'https://ghiaa.org/wp-content/uploads/2020/07/cropped-puzzle-3-270x270.png'}
{'property': 'og:locale', 'content': 'en_US'}
{'property': 'og:site_name', 'content': 'GHIAA'}
{'property': 'og:title', 'content': 'Home'}
{'property': 'og:url', 'content': 'https://ghiaa.org'}
{'property': 'og:type', 'content': 'website'}
{'property': 'og:description', 'content': 'The Global Healthcare Innovation Alliance Accelerator (GHIAA)\t\t\n\t\t\tPolicy to Impact\t\t\n\t\t\tGHIAA creates resources, curates information, collaborates with stakeholders and provides consulting support related to policies and agreement provisions that aim to achieve equitable, global access to medical p'}
{'property': 'og:image', 'content': 'https://ghiaa.org/wp-content/uploads/2020/08/Artboard-10.png'}
{'property': 'og:image:url', 'content': 'https://ghiaa.org/wp-content/uploads/2020/08/Artboard-10.png'}
{'property': 'og:image:secure_url', 'content': 'https://ghiaa.org/wp-content/uploads/2020/08/Artboard-10.png'}
{'name': 'twitter:title', 'content': 'Home'}
{'name': 'twitter:url', 'content': 'https://ghiaa.org'}
{'name': 'twitter:description', 'content': 'The Global Healthcare Innovation Alliance Accelerator (GHIAA)\t\t\n\t\t\tPolicy to Impact\t\t\n\t\t\tGHIAA creates resources, curates information, collaborates with stakeholders and provides consulting support related to policies and agreement provisions that aim to achieve equitable, global access to medical p'}
{'name': 'twitter:image', 'content': 'https://ghiaa.org/wp-content/uploads/2020/08/Artboard-10.png'}
{'name': 'twitter:card', 'content': 'summary'}
{'name': 'twitter:site', 'content': '@GHIAAteam'}

Body Text:
GHIAA – The Global Health Innovation Alliance Accelerator
Skip to content
Envelope
Linkedin-in
Twitter
Home
Our Work
Consulting
MAPGuide
Vaccine Manufacturing
About
About GHIAA
Team
News
GHIAA News
Newsletter
Contact
search
Menu
Home
Our Work
Consulting
MAPGuide
Vaccine Manufacturing
About
About GHIAA
Team
News
GHIAA News
Newsletter
Contact
search
Search for:
search
The Global Healthcare Innovation Alliance Accelerator (GHIAA)
Policy to Impact
GHIAA creates resources, curates information, collaborates with stakeholders and provides consulting support related to policies and agreement provisions that aim to achieve equitable, global access to medical products.
Our Work
MAPGuide
Ⓡ
Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuide
Ⓡ
Platform
The MAPGuide
Ⓡ
platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products. 

Resources on the platform include our
Provision Database
,
Equitable Access Toolkit
, and
Equitable Access Glossary
.
Access MAPGuide
Ⓡ
Platform
Consulting Services
Expert advice for access policies, provisions and plans
Consulting Services
Our team has substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of  access policies and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing
initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
MAPGuide
Ⓡ
Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuide
Ⓡ
Platform
The MAPGuide
Ⓡ
platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products. 

Resources on the platform include our
Provision Database
,
Equitable Access Toolkit
, and
Equitable Access Glossary
.
Access MAPGuide
Ⓡ
Platform
Strategic Insights
For new vaccine manufacturing
initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
Consulting Services
Expert advice for access policies, provisions and plans
Consulting Services
Our team has substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of  access policies and agreement provisions.
Find out more
Sign up to our Newsletter
Latest News
April 10, 2024
Jule to Speak at Conference on Resolving Vaccine Equity
Julie is an invited speaker at the British Academy Conference on Resolving Vaccine Inequity. Hosted at the SOAS University of London from April 11-12, this year’s conference theme is Resolving Global Vaccine Inequality: Innovation, Capabilities and Governance. Julie will be speaking during the “Vaccine Nationalism, Vaccine Inequity, Production and IPR” session starting at 1:30pm BST on April 11 and will specifically address intellectual property rights, pharma product licensing, and global public health security.
Register and learn more.
March 27, 2024
Ongoing Review of the Pandemic Accord
GHIAA has published comprehensive comments and recommendations regarding the most recent negotiating texts for the Pandemic Agreement.
Read Our Commentary Here
March 6, 2024
GHIAA to Participate in Salzburg Global Seminar
Julie will be participating in the Salzburg Global Seminar’s event, “Better Preparedness for the Next Pandemic: Developing Vaccine Access Models with Low- and Middle- Income Countries” from March 11- 16. Targeted outcomes of the event include establishing key principles in the design of a new mechanism for global counter-measures, which could be brought forward to international decision takers, and
providing a narrative record to capture practical insights that informed this design of next-generation multilateral procurement mechanisms for pandemics and outbreaks.
Learn more about the program here.
November 27, 2023
GHIAA Releases the Equitable Access Glossary
GHIAA is pleased to share The Equitable Access Glossary, a new tool designed to help a variety of stakeholders understand commonly used terms in the  development, negotiation, and implementation of policies and agreements that aim to support equitable access to medical products.
Access the Glossary Here.
The development of the MAPGuide
Ⓡ
platform and Equitable Access Toolkit was supported by the Wellcome Trust (grant numbers 219632/Z/19/Z, 221648/Z/20/Z and 225262/Z/22/Z).
If you are interested in providing funding or an in-kind contribution to support GHIAA’s continuing equitable access advocacy work and resource development activities, please contact us using the form below.
Global Healthcare Innovation Alliance Accelerator is a 501(c)(3)
non-profit recognized by the IRS.
Contact Us
Send
Get In Touch
comms@ghiaa.org
Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833
Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA
Browse
Home
MAPGuide
About GHIAA
Team
News
Contact Us
Send
Get In Touch
comms@ghiaa.org
Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833
Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA
Browse
Home
MAPGuide
About GHIAA
Team
News
Twitter
Linkedin-in
Envelope
comms@ghiaa.org
Privacy Policy
Privacy Policy
Menu
Privacy Policy
© 2024 Global Healthcare Innovation Alliance Accelerator. All Rights Reserved
Sign Up to Our Newsletter
Receive updates about GHIAA’s latest tools, resources and news.
I consent to receiving email updates from GHIAA and have read and agree to the
Privacy Policy
and
Terms of Service
.
.
Submit
Agreement Type
Any Agreement Types
Contract Manufacturing
License
Other
R&D Collaboration
R&D Funding
Supply/Purchase
Technology Transfer
Select Partner Type
Any Partner types
Academic institution
Funder
Government
Industry
Multilateral organization
Non-profit research organization
Product development partnership
Select Development Stage
Any Develoment stages
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing
Select Technology
Any Technologies
Device
Diagnostic
Drug
Vaccine
Select Issue or Sub-issues
+
Equitable Access
All Equitable Access
Donation
Ensuring continuity
Access plans & principles
Preparedness & response
Affordable pricing
Territory access commitments
+
Business model
All Business model
Benefit sharing
Regulatory strategy
Governance
Payment Structures
Product supply
+
Protecting & sharing information
All Protecting & sharing information
Confidentiality
Information sharing
Publication of Results
Technology transfer
+
Intellectual Property
All Intellectual Property
License Grants
Ownership of IP
Protection of IP
+
Liability
All Liability
Indemnification & liability
Insurance
Representations & Warranties
+
Term & termination
All Term & termination
Effects of termination
Term of agreement
Termination & withdrawal
